A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Post-Approval Study of the Glaukos iStent Trabecular Micro-Bypass Stent System in Conjunction with Cataract Surgery
ClinicalTrials.gov NCT01841450
Research payments
$992,298
Through program year 2021, $992,298 in research payments was reported against A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Post-Approval Study of the Glaukos iStent Trabecular Micro-Bypass Stent System in Conjunction with Cataract Surgery, across 405 payments, paid by Glaukos Corporation.
- Paid by
- Glaukos Corporation
- ClinicalTrials.gov
- NCT01841450
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $99,124 | 69 |
| 2020 | Research | $374,405 | 149 |
| 2019 | Research | $518,769 | 187 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Damien Goldberg Torrance, CA Named on 29 payments
- Anup Khatana Cincinnati, OH Named on 28 payments
- Cathleen McCabe Bradenton, FL Named on 27 payments
- John Berdahl Sioux Falls, SD Named on 27 payments
- Stephen Tate Vero Beach, FL Named on 26 payments
- William Flynn San Antonio, TX Named on 24 payments
- Jitendra Swarup Elizabeth City, NC Named on 22 payments
- Jacob Brubaker Oklahoma City, OK Named on 21 payments
- Sebastian Heersink Dothan, AL Named on 18 payments
- Patrick Chin Westwood, NJ Named on 16 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.